- » Aim and Scope
- » Section Policies
- » Peer Review Process
- » Publication Frequency
- » Open Access Policy
- » Archiving
- » Peer-Review
- » Indexation
- » Publishing Ethics
- » Founder
- » Author fees
- » Disclosure and Conflict of Interest
- » Plagiarism detection
- » Preprint and postprint Policy
Aim and Scope
Improving the knowledge of infectious diseases physicians, epidemiologists, microbiologists, parasitologists and immunologists of the Far Eastern Federal District is the of the journal priorities as well as improving the quality of medical care of the population of the Russian Federation.
The scientific concept of the journal involves publication of latest achievements in the fields of prevention, diagnosis and therapy of infectious diseases, including results of scientific and clinical research.
Each issue involves selection of most demanded and trustworthy latest materials written by both well-known and young, novice authors.
Section Policies
Open Submissions Open Submissions |
Indexed |
Peer Reviewed |
| Open Submissions |
Indexed |
Peer Reviewed |
| Open Submissions |
Indexed |
Peer Reviewed |
Peer Review Process
Все, поступившие в редакцию журнала «Дальневосточный журнал инфекционной патологии» научные статьи, проходят обязательное одностороннее анонимное («слепое») рецензирование (авторы рукописи не знают рецензентов и получают письмо с замечаниями за подписью главного редактора). Рецензирование статей осуществляется членами редакционного совета и редакционной коллегии, а также приглашенными рецензентами – специалистами в соответствующей отрасли научных знаний. Решение о выборе того или иного рецензента для проведения экспертизы статьи принимает главный редактор, заместитель главного редактора, Срок рецензирования составляет 2-4 недели, однако по просьбе рецензента он может быть продлен. Каждый рецензент имеет право отказаться от рецензии в случае наличия явного конфликта интересов, отражающегося на восприятии и интерпретации материалов рукописи.
По итогам рассмотрения рукописи рецензент даёт рекомендации о дальнейшей судьбе статьи (каждое решение рецензента обосновывается): статья рекомендуется к публикации в настоящем виде; статья рекомендуется к публикации после исправления отмеченных рецензентом недостатков; статья нуждается в дополнительном рецензировании другим специалистом; статья не может быть опубликована в журнале.
При наличии в рецензии рекомендаций по исправлению и доработке статьи, редакция журнала направляет автору текст рецензии с предложением учесть их при подготовке нового варианта статьи или аргументировано (частично или полностью) их опровергнуть. Доработка статьи не должна занимать более двух месяцев с момента отправки электронного сообщения авторам о необходимости внесения изменений. Доработанная автором статья повторно направляется на рецензирование.
В случае отказа авторов от доработки материалов, они должны в письменной или устной форме уведомить редакцию о своем отказе от публикации статьи. Если авторы не возвращают доработанный вариант по истечении 3 месяцев со дня отправки рецензии, даже при отсутствии сведений от авторов с отказом от доработки статьи, редакция снимает её с учета. В подобных ситуациях авторам направляется соответствующее уведомление о снятии рукописи с регистрации в связи с истечением срока, отведенного на доработку.
При возникновении у автора и рецензентов неразрешимых противоречий относительно рукописи, редколлегия вправе направить рукопись на дополнительное рецензирование. В конфликтных ситуациях решение принимает главный редактор на заседании редакционной коллегии.
Решение об отказе в публикации рукописи принимается на заседании редакционной коллегии в соответствии с рекомендациями рецензентов. Статья, не рекомендованная решением редакционной коллегии к публикации, к повторному рассмотрению не принимается. Сообщение об отказе в публикации направляется автору по электронной почте.
После принятия редколлегией журнала решения о допуске статьи к публикации редакция информирует об этом автора и указывает сроки публикации. Наличие положительной рецензии не является достаточным основанием для публикации статьи. Окончательное решение о публикации принимается редакционной коллегией. В конфликтных ситуациях решение принимает главный редактор. Оригиналы рецензий хранятся в редакции журнала в течение 5 лет.
Publication Frequency
4 выпуска в год
Open Access Policy
"Far Eastern Journal of Infectious Pathology" is an open access journal. All articles are made freely available to readers immediatly upon publication.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition - it means that articles have free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself.
For more information please read BOAI statement.
Archiving
- Russian State Library (RSL)
- National Electronic-Information Consortium (NEICON)
Peer-Review
Unilateral anonymous ("blind") peer review is mandatory for all articles submitted to the editorial board of the Far Eastern Journal of Infectious Pathology (This implies that neither the reviewer is aware of the authorship of the manuscript, nor the author maintains any contact with the reviewer. Authors receive a letter with comments signed by the editor-in-chief). Peer reviews are performed by members of the editorial board and editorial council, as well as invited independent experts in corresponding areas of life sciences. Editor-in-chief or deputy editor-in-chief select an expert who examines the article. The review is limited to 2-4 weeks, though the schedule can be extended at the reviewer’s request. Reviewer has an option to abnegate the assessment should any conflict of interest arise and/or affect perception and interpretation of the manuscript.
The reviewer presents following recommendations based on the results of assessment of the manuscript (each reviewer's decision is justified): to accept the paper in its present state; to accept the paper after the author revises the manuscript to address specific concerns of the reviewer; that final decision should be reached following further reviewing by another specialist; to reject the manuscript.
If the reviewer has recommended any refinements, the editorial staff would suggest the author either to implement the corrections (partially or completely), or to dispute them reasonably. Authors are kindly required to limit their revision to 2 months and resubmit the adapted manuscript within this period for final evaluation. The article revised by the author is re-submitted for review.
If the authors refuse to revise the materials, they should notify the editors of their decision in writing or verbally. If the authors fail to do so and do not return the revised version of the paper within 3 months since receiving the review, the editorial board takes the manuscript off the register. If it is the case, the authors will be notified of the withdrawal of the manuscript due to expiration of the period allotted for revision.
If the author and reviewers have insoluble contradictions regarding the manuscript, the editorial board has the right to send the manuscript for additional review. In conflict situations, the decision is made by the editor-in-chief at a meeting of the editorial board.
The decision to refuse publication of the manuscript is made at a meeting of the editorial board in accordance with the recommendations of the reviewers. An article not recommended for publication by the decision of the editorial board is not accepted for reconsideration. The refusal to publish is sent to the author by email.
After the editorial board of the journal makes a decision on the admission of the article for publication, the editorial board informs the author about it and indicates the terms of publication. A positive review is not a sufficient reason for publication of an article. Editorial board makes the final decision on publication. In the event of conflict situations the decision is made by the editor-in-chief. The originals of the reviews are kept in the editorial office of the journal for 5 years.
Indexation
Articles in "Far Eastern Journal of Infectious Pathology" are indexed by several systems:
- Russian Scientific Citation Index (RSCI) – a database, accumulating information on papers by Russian scientists, published in native and foreign titles. The RSCI project is under development since 2005 by “Electronic Scientific Library” foundation (elibrary.ru).
- Google Scholar is a freely accessible web search engine that indexes the full text of scholarly literature across an array of publishing formats and disciplines. The Google Scholar index includes most peer-reviewed online journals of Europe and America's largest scholarly publishers, plus scholarly books and other non-peer reviewed journals.
Publishing Ethics
The editor of the “Far Eastern journal of infectious pathology” is solely and independently responsible for deciding which of the articles submitted to the journal should be published. The reliability and significance of the considered work should be the basis of the decision on publication. The Editor may be guided by the policies of the “Far Eastern journal of infectious pathology” journal’s editorial board. The editor and the editorial board of the “Far Eastern journal of infectious pathology” must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.
Disclosure and Conflicts of interest. Unpublished materials disclosed in a submitted manuscript must not be used in an editor’s own research without the express written consent of the author. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. The editors should recuse themselves (i.e. should ask a co-editor, associate editor or other member of the editorial board instead to review and consider) from considering manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or (possibly) institutions connected with the manuscripts.
Duties of Reviewers. Any selected reviewer who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor of “Far Eastern journal of infectious pathology” and excuse himself from the review process. Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Reviewers should express their views clearly with supporting arguments.
Confidentiality. Each manuscript received for the review must be treated as confidential document. It must not be shown to or discussed with anyone except authorized by the editor.
Requirements for manuscripts and impartiality. Reviewers should identify relevant published work that has not been cited by the authors. Any statement (observation, derivation, or argument) previously reported should be accompanied by a relevant citation. A reviewer should also call to the editor’s attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.
Disclosure and Conflicts of interest. Unpublished materials disclosed in a submitted manuscript must not be used in an editor’s own research without a written consent of the author. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should not evaluate manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or other institutions connected to the papers.
Founder
- FBUN Khabarovsk research institute of epidemiology and microbiology of the Federal service for surveillance on consumers rights protection and human wellbeing (Rospotrebnadzor)
Author fees
Publication in “Far Eastern Journal of Infectious Pathology" is free of charge for all the authors.
The journal doesn't have any Arcticle processing charges.
The journal doesn't have any Article submission charges.
Disclosure and Conflict of Interest
Unpublished materials disclosed in a submitted manuscript must not be used in a reviewer’s own research without the express written consent of the author. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage.
Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.
Plagiarism detection
“Far Eastern Journal of Infectious Pathology" use native russian-language plagiarism detection software Antiplagiat to screen the submissions. If plagiarism is identified, the COPE guidelines on plagiarism will be followed.
Preprint and postprint Policy
Prior to acceptance and publication in “Far Eastern Journal of Infectious Pathology", authors may make their submissions available as preprints on personal or public websites.
As part of submission process, authors are required to confirm that the submission has not been previously published, nor has been submitted. After a manuscript has been published in “Far Eastern Journal of Infectious Pathology" we suggest that the link to the article on journal's website is used when the article is shared on personal or public websites.
Glossary (by SHERPA)
